E. Jungmann, PH. Althoff; S. Balzer-Kuna; W. Magnet; U. Rottmann-Kuhnke; R. Sprey; U. Schwedes; KH. Usadel; K. Schöffling, The inhibiting effect of trilostane on testosterone synthesis. Hormonal and morphologic alterations induced by subchronic trilostane treatment in rats and healthy volunteers., in Arzneimittelforschung, vol. 33, n. 5, 1983, pp. 754-6, PMID6409130.
P. Komanicky, RF. Spark; JC. Melby, Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis., in J Clin Endocrinol Metab, vol. 47, n. 5, Nov 1978, pp. 1042-51, PMID233687.
CG. Semple, GH. Beastall; CE. Gray; JA. Thomson, Trilostane in the management of Cushing's syndrome., in Acta Endocrinol (Copenh), vol. 102, n. 1, Jan 1983, pp. 107-10, PMID6297208.
B. Winterberg, H. Vetter, [Therapy of primary aldosteronism with trilostane]., in Schweiz Med Wochenschr, vol. 113, n. 46, Nov 1983, pp. 1735-8, PMID6658419.
B. Winterberg, W. Vetter; H. Groth; P. Greminger; H. Vetter, Primary aldosteronism: treatment with trilostane., in Cardiology, 72 Suppl 1, 1985, pp. 117-21, PMID3863713.
JN. Ingle, JE. Krook; DJ. Schaid; LK. Everson; JA. Mailliard; HJ. Long; GW. McCormack, Evaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposure., in Am J Clin Oncol, vol. 13, n. 2, Apr 1990, pp. 93-7, PMID2316487.